Trial Information
Descriptive Study to Evaluate the Information and Psychosocial Issues on the Risk on Infertility in Cancer Patients After Receiving Treatment in a Comprehensive Cancer Center
OBJECTIVES:
Primary
- To determine the amount of information received on aspects of fertility and infertility
in patients with cancer prior to receiving treatment in a comprehensive cancer center.
Secondary
- To analyze whether the information received by patients is related to the desire to be
parents.
- To analyze whether the information received by patients is related to the desire to be
informed.
- To determine whether there is a relationship between demographic data, diagnosis,
quality of life, and associated psychosocial information received by patients.
OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information
received prior to therapy and psychosocial issues on aspects of fertility and infertility
once within 1-2 years after receiving treatment.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or
sarcoma
- Free of disease
- Completed treatment within the past 1-2 years
PATIENT CHARACTERISTICS:
- ECOG performance status 0-1
- Must be able to read and self-complete study questionnaires
- No psychological conditions that may prevent participation in the study
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No concurrent treatment (hormonal treatment for breast cancer is allowed)
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
Amount of information received on aspects of fertility and infertility
Safety Issue:
No
Principal Investigator
Josefina Rivera, RGN, MSN
Investigator Role:
Principal Investigator
Investigator Affiliation:
Institut Catala D'Oncologia
Authority:
Unspecified
Study ID:
CDR0000695000
NCT ID:
NCT01295463
Start Date:
December 2010
Completion Date:
Related Keywords:
- Cancer
- sexual dysfunction
- psychosocial effects of cancer and its treatment
- infertility
- colon cancer
- male breast cancer
- breast cancer
- germ cell tumor
- ovarian sarcoma
- uterine sarcoma
- chronic lymphocytic leukemia
- osteosarcoma
- chronic myelogenous leukemia
- non-Hodgkin lymphoma
- adult acute myeloid leukemia with 11q23 (MLL) abnormalities
- adult acute myeloid leukemia with inv(16)(p13;q22)
- adult acute myeloid leukemia with t(15;17)(q22;q12)
- adult acute myeloid leukemia with t(16;16)(p13;q22)
- adult acute myeloid leukemia with t(8;21)(q22;q22)
- mast cell leukemia
- hairy cell leukemia
- prolymphocytic leukemia
- adult acute lymphoblastic leukemia
- adult acute myeloid leukemia
- adult Hodgkin lymphoma
- adult T-cell leukemia/lymphoma
- small intestine lymphoma
- anaplastic large cell lymphoma
- angioimmunoblastic T-cell lymphoma
- mycosis fungoides/Sezary syndrome
- intraocular lymphoma
- primary central nervous system non-Hodgkin lymphoma
- primary central nervous system Hodgkin lymphoma
- noncutaneous extranodal lymphoma
- secondary acute myeloid leukemia
- acute undifferentiated leukemia
- central nervous system leukemia
- T-cell large granular lymphocyte leukemia
- atypical chronic myeloid leukemia, BCR-ABL1 negative
- clear cell sarcoma of the kidney
- Kaposi sarcoma
- adult soft tissue sarcoma
- chronic myelomonocytic leukemia
- secondary central nervous system Hodgkin lymphoma
- cutaneous lymphoma
- adult non-Hodgkin lymphoma
- Infertility